Coherus Oncology Inc (CHRS)

Jun 06, 2025

Coherus BioSciences, Inc. (CHRS): A Bull Case Theory - Insider Monkey

Jun 06, 2025

Jun 04, 2025

Coherus at Jefferies Conference: Strategic Growth and Pipeline Focus - Investing.com

Jun 04, 2025

May 30, 2025

Coherus Oncology (CHRS) Shifts Focus with New Name and Innovativ - GuruFocus

May 30, 2025

May 30, 2025

Coherus Biosciences Rebrands to Coherus Oncology - TipRanks

May 30, 2025

May 30, 2025

Coherus Completes Strategic Transformation to Coherus Oncology, - GuruFocus

May 30, 2025

May 30, 2025

Coherus Completes Strategic Transformation to Coherus Oncology, Focusing Exclusively on Innovative Cancer Therapeutics | CHRS Stock News - GuruFocus

May 30, 2025

May 30, 2025

Coherus Completes Strategic Transformation To Coherus Oncology - marketscreener.com

May 30, 2025

May 30, 2025

Coherus Completes Strategic Transformation to Coherus - GlobeNewswire

May 30, 2025

May 30, 2025

Coherus Makes Bold Strategic Shift: Rebrands as Cancer-Focused Powerhouse with 3 Novel Immunotherapies - Stock Titan

May 30, 2025

May 28, 2025

First patient dosed in STORM-Coherus cancer alliance - Business Weekly

May 28, 2025

May 27, 2025

Coherus BioSciences at 6th Annual Oncology Summit: Strategic Shift to Innovation - Investing.com Canada

May 27, 2025

May 27, 2025

Coherus BioSciences, Inc. Announces Clinical Collaboration with STORM Therapeutics to Evaluate STC-15 in Combination with LOQTORZI®? (toripalimab-Ttzi) - marketscreener.com

May 27, 2025

May 27, 2025

Coherus BioSciences (CHRS) Engages in New Cancer Treatment Colla - GuruFocus

May 27, 2025

May 27, 2025

Coherus BioSciences (CHRS) Engages in New Cancer Treatment Collaboration | CHRS Stock News - GuruFocus

May 27, 2025

May 27, 2025

Coherus Announces Clinical Collaboration with STORM Therapeutics - GuruFocus

May 27, 2025

May 27, 2025

Coherus Announces Clinical Collaboration with STORM Therapeutics to Evaluate STC-15 in Combination with LOQTORZI® (toripalimab-tpzi) | CHRS Stock News - GuruFocus

May 27, 2025

May 27, 2025

Coherus Announces Clinical Collaboration with STORM Therapeutics to Evaluate STC-15 in Combination with LOQTORZI® (toripalimab-tpzi) - The Manila Times

May 27, 2025

May 27, 2025

Coherus Announces Clinical Collaboration with STORM - GlobeNewswire

May 27, 2025

May 27, 2025

Breakthrough Cancer Trial Launches: LOQTORZI Combination Study Targets 4 Major Cancer Types - Stock Titan

May 27, 2025

May 22, 2025

Coherus BioSciences’ SWOT analysis: promising pipeline faces clinical hurdles By Investing.com - Investing.com Canada

May 22, 2025

May 22, 2025

Coherus BioSciences’ SWOT analysis: promising pipeline faces clinical hurdles - Investing.com

May 22, 2025

May 20, 2025

StockNews.com Downgrades Coherus BioSciences (NASDAQ:CHRS) to Sell - Defense World

May 20, 2025

May 20, 2025

The Manufacturers Life Insurance Company Takes Position in Coherus BioSciences, Inc. (NASDAQ:CHRS) - Defense World

May 20, 2025

May 18, 2025

Coherus BioSciences, Inc.'s (NASDAQ:CHRS) 32% Dip In Price Shows Sentiment Is Matching Revenues - simplywall.st

May 18, 2025

May 15, 2025

Coherus BioSciences Earnings Call Highlights Transition and Growth - TipRanks

May 15, 2025

May 15, 2025

Some Coherus BioSciences, Inc. (NASDAQ:CHRS) Analysts Just Made A Major Cut To Next Year's Estimates - simplywall.st

May 15, 2025

May 14, 2025

Coherus BioSciences (CHRS) Reports Q1 Loss, Lags Revenue Estimates - MSN

May 14, 2025

May 14, 2025

Coherus BioSciences First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance

May 14, 2025

May 13, 2025

Coherus BioSciences Reports First Quarter 2025 Financial Results and Provides Business Update | CHRS Stock News - GuruFocus

May 13, 2025

May 13, 2025

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025

May 13, 2025

Coherus BioSciences Q1 2025 Earnings Call Transcript - MarketBeat

May 13, 2025

May 13, 2025

Coherus BioSciences Inc (CHRS) Q1 2025 Earnings Call Highlights: Strategic Growth and ... - Yahoo Finance

May 13, 2025

May 13, 2025

Wells Fargo & Company MN Has $85,000 Stock Position in Coherus BioSciences, Inc. (NASDAQ:CHRS) - Defense World

May 13, 2025

May 13, 2025

Coherus BioSciences Inc (CHRS) Q1 2025 Earnings Call Highlights: - GuruFocus

May 13, 2025

May 13, 2025

Coherus BioSciences: Q1 2025 Financial Highlights and Strategic Shift - TipRanks

May 13, 2025

May 12, 2025

Coherus BioSciences (CHRS) Focuses on Oncology After Divestitures - GuruFocus

May 12, 2025

May 12, 2025

Earnings call transcript: Coherus BioSciences sees flat revenue, stock slides post-Q1 2025 - Investing.com Nigeria

May 12, 2025

May 12, 2025

Coherus BioSciences Reports First Quarter 2025 Financial Results and Provides Business Update - ADVFN

May 12, 2025

May 12, 2025

Coherus BioSciences Inc Reports Q1 2025 Results: EPS of $(0.41) Misses Estimate, Revenue at $7.6 Million Falls Short - GuruFocus

May 12, 2025

May 12, 2025

Coherus BioSciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025

May 12, 2025

Coherus BioSciences (CHRS) Reports Q1 Revenue Surge, Faces Share Decline - GuruFocus

May 12, 2025

May 12, 2025

Coherus BioSciences: Q1 Earnings Snapshot - San Antonio Express-News

May 12, 2025

May 12, 2025

Coherus BioSciences Reports Q1 2025 Financial Results and Advances Oncology Portfolio with CHS-114 and LOQTORZI Developments - Nasdaq

May 12, 2025

May 11, 2025

Coherus BioSciences (NASDAQ:CHRS) Rating Lowered to Sell at StockNews.com - Defense World

May 11, 2025

May 10, 2025

COHERUS BIOSCIENCES Earnings Preview: Recent $CHRS Insider Trading, Hedge Fund Activity, and More - Nasdaq

May 10, 2025

May 10, 2025

Coherus BioSciences (CHRS) Q1 Earnings Preview: Declining Revenue Expected - GuruFocus

May 10, 2025

May 09, 2025

Coherus BioSciences Inc expected to post a loss of 21 cents a shareEarnings Preview - TradingView

May 09, 2025